Liping Guo

3.1k total citations
91 papers, 2.3k citations indexed

About

Liping Guo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Liping Guo has authored 91 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 29 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Liping Guo's work include Cancer-related gene regulation (17 papers), Cancer Cells and Metastasis (10 papers) and Epigenetics and DNA Methylation (10 papers). Liping Guo is often cited by papers focused on Cancer-related gene regulation (17 papers), Cancer Cells and Metastasis (10 papers) and Epigenetics and DNA Methylation (10 papers). Liping Guo collaborates with scholars based in China, United States and United Kingdom. Liping Guo's co-authors include Shih Hsin Lu, Wei Jiang, Lizhen Chen, Jing Wang, Yi‐Xin Zeng, Shih‐Hsin Lu, Xiying Yu, Quanli Gao, Hongxia Li and Chunpeng Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Liping Guo

89 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liping Guo China 26 1.3k 722 662 350 261 91 2.3k
Takaaki Takeda Japan 13 1.4k 1.1× 838 1.2× 925 1.4× 334 1.0× 227 0.9× 19 2.6k
Boris Strilić Germany 20 1.5k 1.1× 861 1.2× 469 0.7× 429 1.2× 432 1.7× 24 2.8k
Anne‐Pierre Morel France 19 1.7k 1.3× 1.4k 2.0× 672 1.0× 243 0.7× 219 0.8× 27 2.7k
Qiudong Zhao China 27 1.2k 0.9× 739 1.0× 606 0.9× 164 0.5× 569 2.2× 49 2.5k
Mario Mikula Austria 24 1.8k 1.4× 965 1.3× 633 1.0× 256 0.7× 227 0.9× 53 2.7k
Mercedes Herrera Spain 24 1.2k 0.9× 737 1.0× 794 1.2× 232 0.7× 305 1.2× 47 2.5k
Helen J. Knowles United Kingdom 29 1.3k 1.0× 555 0.8× 830 1.3× 351 1.0× 276 1.1× 63 2.7k
Thomas Winder United States 20 924 0.7× 903 1.3× 362 0.5× 212 0.6× 354 1.4× 35 2.0k
Douglas W. Strand United States 27 1.0k 0.8× 529 0.7× 501 0.8× 835 2.4× 256 1.0× 73 2.4k
Nancy Kerkvliet United States 18 983 0.8× 1.4k 1.9× 862 1.3× 408 1.2× 320 1.2× 30 2.9k

Countries citing papers authored by Liping Guo

Since Specialization
Citations

This map shows the geographic impact of Liping Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liping Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liping Guo more than expected).

Fields of papers citing papers by Liping Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liping Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liping Guo. The network helps show where Liping Guo may publish in the future.

Co-authorship network of co-authors of Liping Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Liping Guo. A scholar is included among the top collaborators of Liping Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liping Guo. Liping Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Liping, et al.. (2025). Cuproptosis gene characterizes the immune microenvironment of diabetic nephropathy. Transplant Immunology. 89. 102175–102175. 2 indexed citations
3.
Guo, Liping, et al.. (2024). The acceleration of cisplatin resistance in colorectal cancer by lncRNA NORAD through regulation of miR-106a-5p/Cyclin D1 axis. Journal of Chemotherapy. 37(8). 723–734. 1 indexed citations
4.
Guo, Liping, et al.. (2024). Role of Th2, Th17 and Treg Cells and relevant cytokines in pathogenesis of allergic rhinitis. Allergy Asthma and Clinical Immunology. 20(1). 40–40. 7 indexed citations
5.
Guo, Huidong, Liping Guo, Bixia Wang, et al.. (2024). Distinct Immune Homeostasis Remodeling Patterns after HLA‐Matched and Haploidentical Transplantation. Advanced Science. 11(39). e2400544–e2400544. 9 indexed citations
6.
Guo, Liping, et al.. (2022). Identification of Potential Biological Factors Affecting the Treatment of Ticagrelor After Percutaneous Coronary Intervention in the Chinese Population. SHILAP Revista de lepidopterología. 2 indexed citations
7.
Li, Haining, Liping Guo, & Zhigang Cai. (2022). TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma. World Journal of Surgical Oncology. 20(1). 20 indexed citations
8.
Zhang, Yi, Liping Guo, Bingqing Shang, et al.. (2022). A signature for pan-cancer prognosis based on neutrophil extracellular traps. Journal for ImmunoTherapy of Cancer. 10(6). e004210–e004210. 133 indexed citations
10.
Li, Jing, et al.. (2020). Correlation of contrast-enhanced ultrasound features with prognostic factors in invasive ductal carcinomas of the breast. Japanese Journal of Radiology. 38(10). 960–967. 5 indexed citations
11.
Chen, Bo, Guochun Zhang, Guangnan Wei, et al.. (2020). Heterogeneity of genomic profile in patients with HER2-positive breast cancer. Endocrine Related Cancer. 27(3). 153–162. 26 indexed citations
12.
Guo, Liping, Bo Chen, Guochun Zhang, et al.. (2020). The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer. Gene. 759. 144970–144970. 3 indexed citations
13.
Zhang, Xinxin, Xiying Yu, Zhenguo Zhao, et al.. (2019). MicroRNA-429 inhibits bone metastasis in breast cancer by regulating CrkL and MMP-9. Bone. 130. 115139–115139. 26 indexed citations
14.
Yu, Xiying, Xingran Jiang, Hongxia Li, et al.. (2013). miR-203 Inhibits the Proliferation and Self-Renewal of Esophageal Cancer Stem-Like Cells by Suppressing Stem Renewal Factor Bmi-1. Stem Cells and Development. 23(6). 576–585. 78 indexed citations
15.
Lv, Jing & Liping Guo. (2010). Progress on treatment of idiopathic pulmonary fibrosis. Chinese Journal of Asthma. 30(22). 1399–1402. 1 indexed citations
16.
Gao, Quanli, Liping Guo, Chunpeng Zhang, et al.. (2008). Isolation and Identification of Cancer Stem-Like Cells in Esophageal Carcinoma Cell Lines. Stem Cells and Development. 18(3). 465–474. 121 indexed citations
17.
Wang, Jing, Liping Guo, Lizhen Chen, Yi‐Xin Zeng, & Shih Hsin Lu. (2007). Identification of Cancer Stem Cell–Like Side Population Cells in Human Nasopharyngeal Carcinoma Cell Line. Cancer Research. 67(8). 3716–3724. 297 indexed citations
18.
Huang, Ge, Zhanying Hu, Mingyang Li, et al.. (2007). ECRG2 inhibits cancer cell migration, invasion and metastasis through the down-regulation of uPA/plasmin activity. Carcinogenesis. 28(11). 2274–2281. 29 indexed citations
19.
Chai, Lixun, et al.. (2007). [Expression of ezrin and CD44-v6 in human esophageal squamous cell carcinoma and its clinical significance].. PubMed. 29(9). 685–8. 7 indexed citations
20.
Huang, Ge, et al.. (2005). Monoclonal Antibodies to Esophageal Cancer–Related Gene2 Protein. Hybridoma. 24(2). 86–91. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026